These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Endothelium-derived nitric oxide in the control of tissue perfusion and oxygen supply: physiological and pathophysiological implications. Pohl U; Wagner K; de Wit C Eur Heart J; 1993 Nov; 14 Suppl I():93-8. PubMed ID: 8293786 [TBL] [Abstract][Full Text] [Related]
26. [The scientific impact of the nitric oxide discovery as vasodilator and endogenous antithrombotic agent]. Evora PR Arq Bras Cardiol; 1993 Jul; 61(1):3-5. PubMed ID: 8285862 [No Abstract] [Full Text] [Related]
27. Ulster says 'NO'; explosion, resistance and tolerance. Nitric oxide and the actions of organic nitrates. Johnston GD Ulster Med J; 1998 Nov; 67(2):79-90. PubMed ID: 9885543 [No Abstract] [Full Text] [Related]
29. Nitric oxide and cardiovascular system. Cengel A; Sahinarslan A Anadolu Kardiyol Derg; 2006 Dec; 6(4):364-8. PubMed ID: 17162286 [TBL] [Abstract][Full Text] [Related]
30. NO in the cardiovascular system. Shah AM; Vallance P; Harrison D Cardiovasc Res; 1999 Aug; 43(3):507-8. PubMed ID: 10690322 [No Abstract] [Full Text] [Related]
31. Nitric oxide in heart failure: friend or foe. Jugdutt BI Heart Fail Rev; 2002 Oct; 7(4):385-9. PubMed ID: 12379823 [TBL] [Abstract][Full Text] [Related]
32. Reversal of endothelial dysfunction in humans. Hornig B; Drexler H Coron Artery Dis; 2001 Sep; 12(6):463-73. PubMed ID: 11696685 [No Abstract] [Full Text] [Related]
33. Nitric oxide and myocardial function in heart failure: friend or foe? Cotton JM; Kearney MT; Shah AM Heart; 2002 Dec; 88(6):564-6. PubMed ID: 12433878 [TBL] [Abstract][Full Text] [Related]
35. Nitric Oxide Donors and the Treatment of Cardiovascular Disease. Proceedings of a symposium. New Orleans, Louisiana, November 15, 1992. J Cardiovasc Pharmacol; 1993; 22 Suppl 7():S1-58. PubMed ID: 7504761 [No Abstract] [Full Text] [Related]
36. The potential clinical impact of 20 years of nitric oxide research. Cohen RA Am J Physiol; 1999 Apr; 276(4):H1404-7. PubMed ID: 10199869 [No Abstract] [Full Text] [Related]
38. The effects of Thrombospondin-1 on cardiovascular disease: Friend or foe? Mo D; Liu J; Li H Int J Cardiol; 2023 Apr; 377():19. PubMed ID: 36738842 [No Abstract] [Full Text] [Related]
39. The Effects of Dexamethasone on Cardiovascular Disease: Friend or Foe? Han QF; Liu JH; Mo DG Cardiovasc Drugs Ther; 2023 Oct; 37(5):847-848. PubMed ID: 36001199 [No Abstract] [Full Text] [Related]
40. The hemosteoblast: friend or foe? Tintut Y; Demer L Circ Res; 2011 Apr; 108(9):1038-9. PubMed ID: 21527740 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]